People with non-alcoholic fatty liver disease or non-alcoholic steatohepatitis are at particularly high risk for progression to cirrhosis or hepatocellular carcinoma if they have diabetes, say researchers.
Even with newer devices, continuous glucose monitoring underestimates the fall in glucose levels during exercise, with the drop lagging significantly behind that measured by self-monitoring of blood glucose, research shows.
Adolescents who undergo bariatric surgery are more likely than adult patients to have remission of diabetes and hypertension, but require more reoperations, show the 5-year outcomes of the Teen-LABS cohort.
Type 2 diabetes remission can be achieved within 1 year at a cost below the average annual cost of diabetes management, even when including complications, shows an economic evaluation of the DiRECT/Counterweight-Plus weight management program.
Rates of age-standardized all-cause mortality due to diabetes as the underlying or contributing cause of death have plateaued in recent years following earlier declines, shows an analysis of data from the US Census and national mortality database.
Research shows that being diagnosed with type 1 diabetes after the age of 30 years is relatively common, yet people are often misdiagnosed with type 2 diabetes, despite rapid progression to insulin dependence.
Factors associated with poor glycemic control in children with type 1 diabetes generally vary according to the insulin regimen used, but family conflict over diabetes management universally impacts all insulin users, US researchers report.
Delivery of bolus insulin via a patch results in similar glycemic control to that delivered by a conventional pen, with improvements in treatment satisfaction and quality of life, findings from a randomized trial suggest.
People with diabetes and stable ischemic heart disease are more likely to have long-term survival when they have a greater number of risk factors controlled at prespecified therapeutic goals, research shows.
Research published in JAMA shows similar outcomes for patients with center-involved diabetic macular edema and good visual acuity over the first 2 years after diagnosis, regardless of whether they are managed with aflibercept, laser photocoagulation, or observation.
People with type 1 diabetes at high hypoglycemia risk using insulin pumps have fewer hypoglycemic events if the pump is linked to a continuous glucose monitor and has a suspend-before-low feature, SMILE study data show.
Structured transition support improves clinic attendance, satisfaction with care, and diabetes-related distress in people with type 1 diabetes moving from pediatric to adult care, but only for the duration of the program, Canadian research shows.
A post-hoc analysis of the ADVANCE trial indicates that people with type 2 diabetes may benefit from additional antihypertensive medications even if their blood pressure is already below the 140/90 mmHg target.